Cleared Traditional

K132092 - ESTEYA

K132092 is an FDA 510(k) clearance for ESTEYA, manufactured by Nucletron B.V.. The device is a Class 2 Radiology device with product code JAD cleared through the Traditional 510(k) pathway after a 83-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2013
Decision
83d
Days
Class 2
Risk

K132092 is an FDA 510(k) clearance for the ESTEYA. Classified as System, Therapeutic, X-ray (product code JAD), Class II - Special Controls.

Submitted by Nucletron B.V. (Rice Lake, US). The FDA issued a Cleared decision on September 26, 2013 after a review of 83 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5900 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nucletron B.V. devices

FDA 510(k) Submission Details - K132092

510(k) Number K132092 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2013
Decision Date September 26, 2013
Days to Decision 83 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 107d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAD Device Classification - Class 2, Special Controls

Product Code JAD System, Therapeutic, X-ray
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5900
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAD System, Therapeutic, X-ray

All 40
Devices cleared under the same product code (JAD) and FDA review panel - the closest regulatory comparables to K132092.
Axxent Electronic Brachytherapy System Model 110 XP 1200
K153570 · Icad, Inc. · Feb 2016
Sensus Healthcare Superficial X-ray Radiation Therapy System with Ultrasonic Imaging Capabilities
K150037 · Sensus Healthcare · Oct 2015
AXXENT CERVICAL APPLICATOR
K141343 · Icad, Inc. · Sep 2014
SENSUS HELTHCARE IMAGE-DUIDED SUPERFICIAL RADIOTHERAPY SYSTEM
K131582 · Sensus Healthcare · Aug 2013
INTRABEAM FLAT APPLICATOR, INTRABEAM SURFACE APPLICATOR
K130549 · Carl Zeiss Meditec, Inc. · Jun 2013
SENSUS HEALTHCARE SUPERFICIAL RADIOTHERAPY SYSTEM SRT-100
K123985 · Sensus Healthcare · May 2013